HCA Healthcare, Inc. 8-K

What Happened

• On January 27, 2026, HCA Healthcare, Inc. issued a press release (filed as Exhibit 99.1) announcing its results of operations for the fourth quarter and year ended December 31, 2025. The company also disclosed two board actions the same day: authorization of an additional share repurchase program of up to $10 billion and declaration of a quarterly cash dividend of $0.78 per share.
• The declared dividend is payable March 31, 2026, to stockholders of record at the close of business on March 17, 2026. The Form 8‑K was signed by Michael A. Marks, Executive Vice President and Chief Financial Officer.

Key Details

• Press release date and filing: January 27, 2026 (Exhibit 99.1) — announces Q4 and FY2025 results.
• Share repurchase authorization: up to $10.0 billion of common stock; repurchases may occur in the open market or via negotiated transactions.
• Quarterly dividend: $0.78 per share; payment date March 31, 2026; record date March 17, 2026.
• Regulation FD disclosure: results and related information were broadly disseminated via the press release.

Why It Matters

• The earnings release provides the latest information on HCA’s quarterly results and full‑year performance (earnings, revenue and other metrics will be in the press release/exhibit), which investors use to assess operational and financial trends.
• A $10 billion buyback authorizes significant share repurchases, which can reduce shares outstanding and potentially support earnings per share over time.
• The declared cash dividend is a direct return of capital to shareholders and sets the near‑term yield expectation.
• Together, the reported results and the board’s capital-allocation actions (buyback and dividend) are key inputs for investors evaluating HCA’s financial health and shareholder-return strategy.